| ezrin在乳腺癌中的表达及其临床意义 |
| |
| 引用本文： | 李文广,张燕妮,颜海,凌黎,李京微,姜海英,李艳芳. ezrin在乳腺癌中的表达及其临床意义[J]. 中国综合临床, 2006, 25(1): 699-701. DOI: 10.3760/cma.j.issn.1008-6315.2009.07.010 |
| |
| 作者姓名： | 李文广 张燕妮 颜海 凌黎 李京微 姜海英 李艳芳 |
| |
| 作者单位： | 江苏省徐州市肿瘤医院肿瘤内科,221005;江苏省徐州市肿瘤医院普外科,221005;江苏省徐州市肿瘤医院病理科,221005; |
| |
| 基金项目： | 徐州市卫生局科技计划项目 |
| |
| 摘 要： | ![]()
Objective To study the expression and clinical significance of ezrin in breast carcinoma. Methods Immunohistuchemieal staining(S-P) was used to detect the expression of ezrin in 63 cases of breast car-cinoma samples. Results Among these 63 samples,the total expression rates of ezrin were 55.56% (35/63). With the increasing of axillary lymph nodes metastasis and clinical staging,the rates of expressing of ezrin elevated (P<0.05),which was remarkably lower in patients whose disease-free survival(DFS) was > 5 years,or those whose DFS≤5 years or died within five years(P<0.05) ,but the expression of ezrin was not correlated with tumor size,age and menopausal status (P>0.05). Conclusion The expression of ezrin may contribute to prognostic e-valuation for breast carcinoma.
|
| 关 键 词： | 乳腺癌 免疫组化 预后 |
Expression and clinical significance of ezrin in breast carcinomas |
| |
| Abstract: | ![]()
|
| |
| Keywords: | ezrinEzrinBreast carcinomaImmunohistochemistryPrognosis |
|
|
